ANZDATA Epidemiology Fellow

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
ANZDATA Registry Annual Report 2013 CANCER CHAPTER 10.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Allocation of deceased donor kidneys Phil Clayton NSW Renal Group 14 June 2012.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Preparing for a Kidney Transplant: Five Things To Know and Do Niraj M Desai, MD Director of the Kidney and Pancreas Transplant Program Johns Hopkins Hospital.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
Access to renal transplantation Chris Dudley UKRR/UKT Joint analysis.
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
Carolinas Medical Center, Charlotte, NC Website:
Obesity in the end stage kidney disease population
Stephen P. McDonald, Graeme R. Russ  Kidney International 
UK Renal Registry 13th Annual Report
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
ANZDATA session ANZSN-ASM 2017
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
Research Developments in the Registry
UK Renal Registry 10th Annual Report 2007
Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases  Gerhard Lonnemann, Johannes Duttlinger,
Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.
John P. Dickerson, Tuomas Sandholm In AAAI, 2015
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Alina M. Allen MD, Patrick S. Kamath MD, Joseph J. Larson,
Summary of the 2013 ERA-EDTA Registry Annual Report
2015 Kidney Allocation Task Force HLA Working Group
Number of transplants, by donor type figure 8.1
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
Clinical outcome after SVR: Veterans Affairs
Liver only transplants in the UK Question 2: In terms of survival benefit.
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
Kidney allocation to highly sensitized patients
CHAPTER 5 Paediatric Renal Replacement Therapy
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
Clinical outcome after SVR: ANRS CO22 HEPATHER
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
West Midlands Renal Peer Review
Steven J. Chadban, Natalie D. Staplin  Kidney International 
(A) Kaplan-Meier renal survival estimates of patients with diabetic nephropathy (DN), non-diabetic renal disease (NDRD) and mixed groups, adjusting for.
Volume 67, Issue 4, Pages (April 2005)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia  Blair S. Grace, Philip A. Clayton, Alan.
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
UK Renal Registry 14th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Stephen P. McDonald, Graeme R. Russ  Kidney International 
JAMA Internal Medicine 2018;178(11):
Volume 83, Issue 3, Pages (March 2013)
Update from the Haemodialysis Working Group
Dialysis outcomes in Australia & New Zealand
Number of Donors in Australia
Number of Donors in Australia
ANZDATA Paediatric Report
ANZDATA: Vascular Access
Acute Rejection in ANZ TSANZ 2003
Presentation transcript:

ANZDATA Epidemiology Fellow Matthew Sypek Activity report Transplant wait listing in Australia

The ANZDATA Epidemiology Fellowship Stephen McDonald 2001-2005 Andrew Brunskill 2008 Namrata Khanal 2014-2015 Sean Chang 2006-2007 Phil Clayton 2010-2013 Matthew Sypek 2017-

Internal Research Priorities Transplant waiting list; organ discard rates; Impact of KDPI reporting; cause of death coding; travel time analysis Internal Research Priorities Adrian Hibberd: Restored Kidney Transplantation; David Semple: Outcomes in HHDx; Suetonia Palmer; Late referral in NZ; Kathy Pazis: Machine Learning techniques in Organ Allocation Research Collaborations HLA epitope based matching in paediatric renal transplantation Organ allocation for highly sensitized patients HLA epitope based organ allocation Personal Research Projects Research Community preferences for organ allocation – Kirsten Howard/Martin Howell PROMS Ethical aspects of organ allocation policy BEAT CKD Program Review Liaise, clarify, explain and assist Extract and review code Requests Management Updating and establishing MoU for data sharing Revising internal policies and procedures review Reviewing data collection eg Primary Renal Disease coding Service Improvement Service Delivery and Development Data entry queries Statistical analysis Reviewing content of ANZDATA reports Clinical Input in to Registry Activities ANZDATA Education Forum External Events: ANZDATA symposium, BEAT CKD Individualized education for contributors and stakeholders Education

Wait-listing for Kidney Transplantation in Australia

Treatment of End Stage Kidney Disease ESKD Conservative care No Suitable for Transplantation? Long-term dialysis Yes Living Donor Transplant Deceased Donor Wait Listing Organ Availability Treatment of End Stage Kidney Disease Organ Allocation Organ Acceptance Deceased Donor Transplant

Treatment of End Stage Kidney Disease ESKD Conservative care No Suitable for Transplantation? Long-term dialysis Yes Living Donor Transplant Deceased Donor Wait Listing Organ Non-Utilisation Organ Availability Community Preferences cPRA Modelling Treatment of End Stage Kidney Disease Organ Allocation HLA Epitopes Ethics of Allocation Organ Acceptance Deceased Donor Transplant

Treatment of End Stage Kidney Disease ESKD Conservative care No Suitable for Transplantation? Long-term dialysis Yes Living Donor Transplant Deceased Donor Wait Listing Organ Non-Utilisation Organ Availability Community Preferences cPRA Modelling Treatment of End Stage Kidney Disease Organ Allocation HLA Epitopes Ethics of Allocation Organ Acceptance Deceased Donor Transplant

Time to Waitlisting Aims To determine the factors associated with time to wait listing and time to transplantation for incident RRT patients in Australia To determine if time to waitlisting is significantly associated with time to transplant To determine the factors associated with time from waitlist to transplant

Inclusion/Exclusion Inclusion criteria: Exclusion criteria: Outcome All incident dialysis patients starting RRT in Australia from July 2006-July 2015 Exclusion criteria: Patients ever wait listed for multi-organ transplant Patients who regained native kidney function Patients < 18 years of age Patients >75 years of age Outcome Event = date of first active listing or date of first transplant Censor = death or date of last follow up

Covariates Age at starting RRT Year of starting RRT Gender Primary renal disease - categories Country of Birth - Australia vs other Ethnic Origin - categories State at commencing RRT Co-morbidites DM, IHD, Lung, PVD, CVD History of Cancer Solid Organ Skin Cancer Smoking status BMI - Categories Late referral SES based on postcode Remoteness based on postcode at starting RRT

Statistical Methods Univariate analysis Multivariate analysis Non-parametric – Kaplan Meier Survival Curves with Log Rank test of significance Semi-parametric – Cox Proportional Hazards Regression Multivariate analysis Piecewise Cox Proportional Hazards Model

Please help get the most out of ANZDATA To read our reports and for more information: www.anzdata.org.au If you know what you need: requests@anzdata.org.au If you have a question or need some advice: matthew@anzdata.org.au